サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1455743

犬用高麗人参サプリメントの世界市場（2023年～2030年）

Global Ginseng Dog Supplement Market - 2023-2030

出版日
ページ情報
英文 200 Pages
納期
即日から翌営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.82円
犬用高麗人参サプリメントの世界市場（2023年～2030年）
出版日: 2024年03月26日
発行: DataM Intelligence
ページ情報: 英文 200 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

概要

犬用高麗人参サプリメントの世界市場は、2022年に1億2,921万米ドルに達し、2030年には2億907万米ドルに達し、予測期間2023年～2030年のCAGRは6.2％で成長すると予測されています。

米国ペット用品協会（APPA）によると、米国人がペットに費やす金額は2021年の1,236億米ドルから2022年には1,368億米ドルに増加しました。高麗人参の犬用サプリメントは、その天然成分と潜在的な健康効果により、しばしばプレミアム製品として販売されています。ペットの飼い主がこうした高級品を求めるようになるにつれて、高麗人参の犬用サプリメントの需要は高まると予想されます。

ペットの飼い主は、ペットのヘルスケアに予防的アプローチを採用するようになってきており、健康問題が発生する前に予防しようとする傾向が強まっています。高麗人参の犬用サプリメントは、免疫力を高め、全体的な健康を増進する特性があるとされ、この予防ヘルスケアアプローチに適しています。各メーカーはこの動向を利用し、犬の総合的な健康増進と加齢に伴う健康問題の予防を目的とした高麗人参サプリメントを開発しています。

関節の健康は、愛犬の関節問題の増加により、市場シェアの半分以上を占めています。同様に、アジア太平洋地域は、漢方薬の豊かな歴史とペットの健康に対する意識の高まりにより、高麗人参サプリメント市場を独占しています。アジアの伝統文化における高麗人参ベースの治療法の人気と、中国、日本、韓国などの国々におけるペット飼育率の上昇が、この市場におけるアジア太平洋の優位性に寄与しています。

市場力学

ペット飼育率の上昇

犬用高麗人参サプリメント市場は、ペット飼育率の上昇により成長を遂げています。米国ペット用品協会の2021-2022年全国ペット所有者調査によると、米国の6,900万世帯がペットとして犬を飼っています。家庭や家族に犬を迎え入れる人が増えるにつれて、ペットの健康と幸福をサポートする製品に対する需要も並行して増加しています。

ペットの飼い主は、高麗人参をベースとした栄養補助食品など、毛皮で覆われた仲間に最高のケアを提供することにますます投資するようになっています。高麗人参は、人間には潜在的な健康効果があるとして崇められ、現在では、エネルギーを高め、免疫機能を強化し、全体的な健康を促進するという利点が認識されているため、ペットケアのレジメンに組み込まれるようになっています。その結果、犬用高麗人参サプリメント市場は、飼い主の進化するニーズと嗜好に応えることで大きな成長を遂げています。

ナチュラルでホリスティックな製品への注目

ナチュラルでホリスティックな製品への注目は、犬用高麗人参サプリメント市場の成長を支える重要な要因です。ペットの飼い主は、従来の医薬品に代わるものを求めるようになっており、ペットの全体的な健康を促進するという信念に沿った自然療法を好むようになっています。高麗人参は、その薬効と伝統医学における長年の使用で知られており、この物語によく合致しています。

さらに、ナチュラルでホリスティックな製品へのシフトは、従来のペット用サプリメントによく見られる合成成分の潜在的な副作用に対する懸念が背景にあります。高麗人参は自然な解決策を提供し、毛皮で覆われた仲間の安全と幸福を優先する飼い主にアピールします。ペットの飼い主が毛皮で覆われた仲間の健康と幸福を優先し続ける中、高麗人参を含む天然ペット用サプリメント市場は大きく成長すると予想されます。

潜在的な健康リスクと副作用

アレルギーや過敏症の可能性は、高麗人参サプリメント市場の成長に大きな抑制要因となっています。高麗人参は一般にほとんどの犬にとって安全であると考えられていますが、高血圧、腎臓病、心筋症の犬には副作用の可能性があるため与えてはいけません。さらに、高麗人参は犬にとって血液をサラサラにする作用があるため、特定の個体にとっては問題となる可能性があります。

さらに、高麗人参を大量に、あるいは長期にわたって過剰に使用すると、抑うつ、食欲不振、血圧低下、アレルギーなどの有害な症状を引き起こす可能性があります。このような潜在的なリスクや副作用は、特に新しいサプリメントの導入に慎重な飼い主や、ペットの健康に不安のある飼い主が、愛犬に高麗人参サプリメントを使用することを躊躇させる可能性があります。

目次

第1章 調査手法と調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

  • 影響要因
    • 促進要因
      • ペット飼育率の上昇
      • ナチュラルでホリスティックな製品への注目
    • 抑制要因
      • 潜在的な健康リスクと副作用
    • 機会
    • 影響分析

第5章 産業分析

  • ポーターのファイブフォース分析
  • サプライチェーン分析
  • 価格分析
  • 規制分析
  • ロシア・ウクライナ戦争の影響分析
  • DMIの見解

第6章 COVID-19分析

第7章 製品別

  • カプセル
  • 錠剤
  • 粉末サプリメント
  • その他

第8章 犬種別

  • 子犬用
  • 成犬用

第9章 高麗人参タイプ別

  • アメリカ人参
  • アジア人参
  • その他

第10章 用途別

  • 関節の健康
  • 免疫系サポート
  • エネルギーと活力
  • 皮膚と被毛の健康
  • 消化器系の健康
  • 血糖値管理
  • その他

第11章 流通チャネル別

  • スーパーマーケット／ハイパーマーケット
  • オンライン小売
  • ペット専門店
  • 動物病院
  • その他商業

第12章 地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • その他欧州
  • 南米
    • ブラジル
    • アルゼンチン
    • その他南米
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • オーストラリア
    • その他アジア太平洋
  • 中東・アフリカ

第13章 競合情勢

  • 競合シナリオ
  • 市況/シェア分析
  • M&A分析

第14章 企業プロファイル

  • GIGI VET
    • 会社概要
    • 製品ポートフォリオと説明
    • 財務概要
    • 主な発展
  • Animal Health Company
  • KIN DOG GOODS
  • Heilsa
  • Ray Allen Manufacturing
  • Happea Chappea Limited
  • Animaux
  • INLIFE Healthcare
  • Royal Pet
  • URANOVET, S.L.

第15章 付録

目次
Product Code: FB8185

Overview

Global Ginseng Dog Supplement Market reached US$ 129.21 million in 2022 and is expected to reach US$ 209.07 million by 2030, growing with a CAGR of 6.2% during the forecast period 2023-2030.

The trend of growing pet expenditure is a significant driver for the growth of various pet supplements including the ginseng dog supplement market According to APPA, American Pet Products Association, The amount that Americans spend on pets increased from $123.6 billion in 2021 to $136.8 billion in 2022. Ginseng dog supplements are often marketed as premium products due to their natural ingredients, and potential health benefits. As pet owners seek out these premium offerings, the demand for ginseng dog supplements is expected to rise.

Pet owners are increasingly adopting a preventive approach to their pets' healthcare, seeking to prevent health issues before they arise. Ginseng dog supplements, with their purported immune-boosting and overall health-enhancing properties, fit into this preventive healthcare approach. Manufacturers are capitalizing on this trend by developing ginseng supplements targeted at promoting overall wellness and preventing age-related health issues in dogs.

Joint health accounts for over half of the market share due to the rising joint issues on pet dogs. Similarly, Asia-Pacific dominates the ginseng dog supplement market driven by the region's rich history of herbal medicine and growing awareness of pet health. The popularity of ginseng-based remedies in traditional Asian cultures and the rising pet ownership rates in countries like China, Japan, and South Korea contribute to the dominance of Asia-Pacific in this market.

Dynamics

Rise in Pet Ownership

The Ginseng Dog Supplement Market is experiencing growth due to the rise in pet ownership. According to the American Pet Products Association's 2021-2022 National Pet Owners Survey, 69 million U.S. households own a dog as a pet. As more individuals choose to welcome dogs into their homes and families, there is a parallel increase in the demand for products that support the health and well-being of these pets.

Pet owners are increasingly invested in providing their furry companions with the best possible care, including nutritional supplements like ginseng-based products. Ginseng, revered for its potential health benefits in humans, is now being recognized and integrated into pet care regimens due to its perceived advantages in boosting energy, enhancing immune function, and promoting overall well-being. Consequently, the ginseng dog supplement market is experiencing significant growth as it meets the evolving needs and preferences of pet owners.

Focus on Natural and Holistic Products

The focus on natural and holistic products is a significant driver behind the growth of the ginseng dog supplement market. Pet owners are increasingly seeking alternatives to traditional pharmaceuticals, preferring natural remedies that align with their beliefs in promoting overall wellness for their pets. Ginseng, known for its medicinal properties and long-standing use in traditional medicine, fits well into this narrative.

Moreover, the shift towards natural and holistic products is driven by concerns about the potential side effects of synthetic ingredients commonly found in traditional pet supplements. Ginseng offers a natural solution, appealing to pet owners who prioritize the safety and well-being of their furry companions. As pet owners continue to prioritize the health and well-being of their furry companions, the market for natural pet supplements, including those containing ginseng, is expected to grow significantly.

Potential Health Risks and Adverse Effects

Potential allergies or sensitivities pose a significant restraint to the growth of the ginseng dog supplement market. While ginseng is generally considered safe for most dogs, it should not be given to dogs with hypertension, kidney disease, or cardiomyopathy due to potential adverse effects. Additionally, ginseng may have blood-thinning effects on dogs, which can be problematic for certain individuals

Moreover, excessive use of ginseng in large quantities or over the long term can lead to adverse symptoms such as depression, loss of appetite, hypotension, and allergies. These potential risks and side effects may deter pet owners from using ginseng supplements for their dogs, particularly those who are cautious about introducing new supplements or have concerns about their pets' health.

Segment Analysis

The global ginseng dog supplement market is segmented based on product, dog type, ginseng type, application, distribution channel and region.

Prevalence of Joint Issues in Dogs

Joint health problems, such as arthritis and hip dysplasia, are common in dogs, particularly as they age. According to the IAABC Foundation Journal, Pet dogs are frequently affected by osteoarthritis (OA). 80% of dogs over 8 years old and 20 percent of dogs over 1 year old have been discovered to have some degree of osteoarthritis. As a result, there is a high demand for supplements that can support joint function and alleviate symptoms associated with these conditions.

Ginseng is believed to have anti-inflammatory properties and may help reduce joint pain and inflammation in both humans and animals. As a result, it is often included as an active ingredient in dog supplements targeting joint health. As awareness of the benefits of ginseng-based supplements spreads, particularly in addressing joint issues, the market share of this application segment increases.

Geographical Penetration

Asia-Pacific's Growing Ginseng Production

Ginseng has a long history of traditional medicinal use in many Asian cultures, including China and Korea. According to Earth Observatory, a part of the EOS Project Science Office at NASA Goddard Space Flight Center, China is the world's leading producer of ginseng. Similarly, according to the Jilin Ginseng Industry Association, 60% of China's ginseng is produced in Jilin. The Jilin ginseng industry's output value hit 64 billion yuan (8.77 billion US dollars) in 2022. With increasing ginseng production in the Asia Pacific region, there is a steady and reliable supply of ginseng and its derivatives.

Moreover, the Asia Pacific region has experienced significant growth in pet ownership, particularly in countries like China, Japan, and South Korea. According to a report released Tuesday by Pethadoop, a platform specializing in China's pet industry, China has 54 million pet dogs as of 2021. As pet owners become more invested in the health and well-being of their pets, they are increasingly seeking out supplements like ginseng to improve their pets' health.

COVID-19 Impact Analysis

With people spending more time at home due to lockdowns and remote work arrangements, there was increased attention on pet health and wellness. This led to a rise in demand for supplements, including those containing ginseng, believed to have health benefits for dogs. Pet owners seek to bolster their pets' immune systems and overall health as a preventative measure against illness, including potential viral infections. Ginseng is often touted for its immune-boosting properties, which made it particularly appealing during a health crisis like Covid-19.

However, COVID-19 has disrupted global supply chains, and affected the availability of raw materials and finished products. This could lead to shortages or delays in the production and distribution of ginseng dog supplements, impacting both manufacturers and consumers. Economic uncertainties resulting from the pandemic affected consumer spending habits. Some pet owners may cut back on non-essential expenses, including supplements, leading to a temporary decline in sales.

Russia-Ukraine War Impact Analysis

The war between Russia and Ukraine affected the supply chain for ginseng or related ingredients used in dog supplements, which led to shortages or price increases. The war led to economic uncertainty, which impacted consumer spending habits. During the war, consumers prioritized essentials over non-essential items such as pet supplements. This led to a temporary decline in demand for premium pet food including ginseng dog supplements.

By Product

  • Capsules
  • Tablets
  • Powdered Supplements
  • Others

By Dog Type

  • Puppy
  • Adult

By Ginseng Type

  • American Ginseng
  • Asian Ginseng
  • Others

By Application

  • Joint Health
  • Immune System Support
  • Energy and Vitality
  • Skin and Coat Health
  • Digestive Health
  • Blood Sugar Management
  • Others

By Distribution Channel

  • Supermarkets/Hypermarkets
  • Online Retail
  • Specialty Pet Stores
  • Veterinary Clinics
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Russia
    • Rest of Europe
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • Rest of Asia-Pacific
  • Middle East and Africa

Key Developments

  • In October 2023, Baumann Ginseng Farm, a ginseng farm in the United States, launched a ginseng joint health supplement for pets. Lonza patent UC-II non-denatured type II collagen, 20 mg per pack, is an ingredient in this product. Along with the advantages of 150 mg of American ginseng extract, it aids in promoting metabolism, nourishing and strengthening the body, and maintaining vitality in pets. It also helps pets retain joint mobility and cartilage health.
  • In June 2022, Charmy Pet, a Canadian pet nutrition company, launched a Kickstarter campaign to launch their new range of freeze-dried pet food. Introducing a new line of freeze-dried formulas that include holistic herbs used in traditional Chinese medicine, the first of its type in North America. Charmy is assisting pet parents in enhancing their dogs' health without the need for synthetic vitamins and supplements by incorporating natural herbs from traditional Chinese medicine, such as ginseng and astragalus root, into pet food.
  • In March 2021, the Ministry of Trade, Industry and Energy and the Korea Chamber of Commerce and Industry approved a request for permission from Pet healthcare start-up Allfin to operate a customized pet food business in a regulatory sandbox. This will allow Koreans to order bowls of samgyetang, a traditional chicken soup with ginseng, for their dogs.

Competitive Landscape

The major global players in the market include GIGI VET, Animal Health Company, KIN DOG GOODS, Heilsa, Ray Allen Manufacturing, Happea Chappea Limited, Animaux, INLIFE Healthcare, Royal Pet, URANOVET, S.L.

Why Purchase the Report?

  • To visualize the global ginseng dog supplement market segmentation based on product, dog type, ginseng type, application, distribution channel, and region as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of ginseng dog supplement market-level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as excel consisting of key products of all the major players.

The global ginseng dog supplement market report would provide approximately 78 tables, 78 figures and 200 Pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1.Methodology and Scope

  • 1.1.Research Methodology
  • 1.2.Research Objective and Scope of the Report

2.Definition and Overview

3.Executive Summary

  • 3.1.Snippet by Product
  • 3.2.Snippet by Dog Type
  • 3.3.Snippet by Ginseng Type
  • 3.4.Snippet by Application
  • 3.5.Snippet by Distribution Channel
  • 3.6.Snippet by Region

4.Dynamics

  • 4.1.Impacting Factors
    • 4.1.1.Drivers
      • 4.1.1.1.1.Rise in Pet Ownership
      • 4.1.1.1.2.Focus on Natural and Holistic Products
    • 4.1.2.Restraints
      • 4.1.2.1.1.Potential Health Risks and Adverse Effects
    • 4.1.3.Opportunity
    • 4.1.4.Impact Analysis

5.Industry Analysis

  • 5.1.Porter's Five Force Analysis
  • 5.2.Supply Chain Analysis
  • 5.3.Pricing Analysis
  • 5.4.Regulatory Analysis
  • 5.5.Russia-Ukraine War Impact Analysis
  • 5.6.DMI Opinion

6.COVID-19 Analysis

  • 6.1.Analysis of COVID-19
    • 6.1.1.Scenario Before COVID
    • 6.1.2.Scenario During COVID
    • 6.1.3.Scenario Post COVID
  • 6.2.Pricing Dynamics Amid COVID-19
  • 6.3.Demand-Supply Spectrum
  • 6.4.Government Initiatives Related to the Market During Pandemic
  • 6.5.Manufacturers Strategic Initiatives
  • 6.6.Conclusion

7.By Product

  • 7.1.Introduction
    • 7.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 7.1.2.Market Attractiveness Index, By Product
  • 7.2.Capsules*
    • 7.2.1.Introduction
    • 7.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3.Tablets
  • 7.4.Powdered Supplements
  • 7.5.Others

8.By Dog Type

  • 8.1.Introduction
    • 8.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Dog Type
    • 8.1.2.Market Attractiveness Index, By Dog Type
  • 8.2.Puppy*
    • 8.2.1.Introduction
    • 8.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3.Adult

9.By Ginseng Type

  • 9.1.Introduction
    • 9.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Ginseng Type
    • 9.1.2.Market Attractiveness Index, By Ginseng Type
  • 9.2.American Ginseng*
    • 9.2.1.Introduction
    • 9.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3.Asian Ginseng
  • 9.4.Others

10.By Application

  • 10.1.Introduction
    • 10.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.1.2.Market Attractiveness Index, By Application
  • 10.2.Joint Health*
    • 10.2.1.Introduction
    • 10.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 10.3.Immune System Support
  • 10.4.Energy and Vitality
  • 10.5.Skin and Coat Health
  • 10.6.Digestive Health
  • 10.7.Blood Sugar Management
  • 10.8.Others

11.By Distribution Channel

  • 11.1.Introduction
    • 11.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 11.1.2.Market Attractiveness Index, By Distribution Channel
  • 11.2.Supermarkets/Hypermarkets*
    • 11.2.1.Introduction
    • 11.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 11.3.Online Retail
  • 11.4.Specialty Pet Stores
  • 11.5.Veterinary Clinics
  • 11.6.Others Commercial

12.By Region

  • 12.1.Introduction
    • 12.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 12.1.2.Market Attractiveness Index, By Region
  • 12.2.North America
    • 12.2.1.Introduction
    • 12.2.2.Key Region-Specific Dynamics
    • 12.2.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 12.2.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Dog Type
    • 12.2.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Ginseng Type
    • 12.2.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 12.2.7.Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 12.2.8.Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 12.2.8.1.U.S.
      • 12.2.8.2.Canada
      • 12.2.8.3.Mexico
  • 12.3.Europe
    • 12.3.1.Introduction
    • 12.3.2.Key Region-Specific Dynamics
    • 12.3.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 12.3.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Dog Type
    • 12.3.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Ginseng Type
    • 12.3.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 12.3.7.Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 12.3.8.Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 12.3.8.1.Germany
      • 12.3.8.2.UK
      • 12.3.8.3.France
      • 12.3.8.4.Italy
      • 12.3.8.5.Spain
      • 12.3.8.6.Rest of Europe
  • 12.4.South America
    • 12.4.1.Introduction
    • 12.4.2.Key Region-Specific Dynamics
    • 12.4.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 12.4.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Dog Type
    • 12.4.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Ginseng Type
    • 12.4.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 12.4.7.Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 12.4.8.Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 12.4.8.1.Brazil
      • 12.4.8.2.Argentina
      • 12.4.8.3.Rest of South America
  • 12.5.Asia-Pacific
    • 12.5.1.Introduction
    • 12.5.2.Key Region-Specific Dynamics
    • 12.5.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 12.5.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Dog Type
    • 12.5.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Ginseng Type
    • 12.5.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 12.5.7.Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 12.5.8.Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 12.5.8.1.China
      • 12.5.8.2.India
      • 12.5.8.3.Japan
      • 12.5.8.4.Australia
      • 12.5.8.5.Rest of Asia-Pacific
  • 12.6.Middle East and Africa
    • 12.6.1.Introduction
    • 12.6.2.Key Region-Specific Dynamics
    • 12.6.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 12.6.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Dog Type
    • 12.6.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Ginseng Type
    • 12.6.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 12.6.7.Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel

13.Competitive Landscape

  • 13.1.Competitive Scenario
  • 13.2.Market Positioning/Share Analysis
  • 13.3.Mergers and Acquisitions Analysis

14.Company Profiles

  • 14.1.GIGI VET*
    • 14.1.1.Company Overview
    • 14.1.2.Product Portfolio and Description
    • 14.1.3.Financial Overview
    • 14.1.4.Key Developments
  • 14.2.Animal Health Company
  • 14.3.KIN DOG GOODS
  • 14.4.Heilsa
  • 14.5.Ray Allen Manufacturing
  • 14.6.Happea Chappea Limited
  • 14.7.Animaux
  • 14.8.INLIFE Healthcare
  • 14.9.Royal Pet
  • 14.10.URANOVET, S.L.

LIST NOT EXHAUSTIVE

15.Appendix

  • 15.1.About Us and Services
  • 15.2.Contact Us